OUR STRATEGY

Performance against Strategy

OUR STRATEGY

Performance against Strategy

human centred collections

Aspiration

  • Enhance donor experience through a human centred approach.
  • Enhance brand advocacy

Strategic Priorities

  • Increase capacity and capability to collect more blood
  • Determine true blood demand
  • Manage deferrals to acceptable levels through strategic initiatives
  • Ensure improved donor outcomes and excellence and deliver excellence in donor care
  • Focus on new donors, youth and black donors

FY22 Highlights

  • # of units Group O whole blood collected was below target; effects of C-19
  • # of units of Apheresis platelets collected exceeded target
  • Days’ cover exceeded target

Contribution to Long-term Sustainable Value

Related Material
Matters

  • Meeting blood demand
  • Future changing world

human centred collections

Aspiration

  • Enhance donor experience through a human centred approach.
  • Enhance brand advocacy

Strategic Priorities

  • Increase capacity and capability to collect more blood
  • Determine true blood demand
  • Manage deferrals to acceptable levels through strategic initiatives
  • Ensure improved donor outcomes and excellence and deliver excellence in donor care
  • Focus on new donors, youth and black donors

FY22 Highlights

  • # of units Group O whole blood collected was below target; effects of C-19
  • # of units of Apheresis platelets collected exceeded target
  • Days’ cover exceeded target

Contribution to Long-term Sustainable Value

Related Material
Matters

  • Meeting blood demand
  • Future changing world

Reflecting on our performance against the 2021/2022 Scorecard and how we added value

Target achieved/exceeded New initiative on track against current plan (no concerns Improvements YOY No Concerns yet Below Target

Reflecting on our performance against the 2021/2022 Scorecard and how we added value

Target achieved/exceeded New initiative on track against current plan (no concerns Improvements YOY No Concerns yet Below Target

Below, we further unpack the various components of our performance against our iHEALTh strategy

Key Measured Initiatives

Below, we further unpack the various components of our performance against our iHEALTh strategy

Key Measured Initiatives

% Deferrals from all donations

Target

  • <15.0%

IR 2021

  • 10.5 %

Progress for FY22

  • 10.15%

target for 2022/2023

  • <15.0%
  • Expanding donor base therefore deferrals increase

% Deferrals from all donations

Target

  • <15.0%

IR 2021

  • 10.5 %

Progress for FY22

  • 10.15%

target for 2022/2023

  • <15.0%
  • Expanding donor base therefore deferrals increase

% Hb Deferrals from all donations Consolidation of all deferrals

Target

  • 7.5% or less

IR 2021

  • 5%

Progress for FY22

  • 4.9%

target for 2022/2023

  • 7.5% or less

% Hb Deferrals from all donations Consolidation of all deferrals

Target

  • 7.5% or less

IR 2021

  • 5%

Progress for FY22

  • 4.9%

target for 2022/2023

  • 7.5% or less

#Ferritin testing - Roll out in Zones

Target

  • Overall objective  is to reduce iron deficiency amongst donors

IR 2021

  • 2

Progress for FY22

  • Developed and implemented ferritin testing algorithms

target for 2022/2023

  • Develop holistic  iron management programme for donors with low ferritin

#Ferritin testing - Roll out in Zones

Target

  • Overall objective  is to reduce iron deficiency amongst donors

IR 2021

  • 2

Progress for FY22

  • Developed and implemented ferritin testing algorithms

target for 2022/2023

  • Develop holistic  iron management programme for donors with low ferritin

No. of source plasma collections

Target

  • 53 848

IR 2021

  • 40 348
  • 74.6% of target

Progress for FY22

  • 39 130

  • 72.6% of target

  • Covid-19 restrictions impact on collections

  • Focus on whole blood & PLCA collections

target for 2022/2023

  • >=64 000

No. of source plasma collections

Target

  • 53 848

IR 2021

  • 40 348
  • 74.6% of target

Progress for FY22

  • 39 130

  • 72.6% of target

  • Covid-19 restrictions impact on collections

  • Focus on whole blood & PLCA collections

target for 2022/2023

  • >=64 000

Days’ cover (Group O Blood)

Target

  • 4

IR 2021

  • 4.6

Progress for FY22

  • 4.1%

target for 2022/2023

  • 5
  • Elective surgeries back to normal post Covid -  increasing demand
  • #MoreBlood initiative started, additional collection teams added to cover additional clinics to compensate for lower collection counts per clinic

Days’ cover (Group O Blood)

Target

  • 4

IR 2021

  • 4.6

Progress for FY22

  • 4.1%

target for 2022/2023

  • 5
  • Elective surgeries back to normal post Covid -  increasing demand
  • #MoreBlood initiative started, additional collection teams added to cover additional clinics to compensate for lower collection counts per clinic

#Of units of Apheresis platelets collected

Target

  • 18 510

IR 2021

  • 18 148 

  • (target  was 16 280)

Progress for FY22

  • 19 627

target for 2022/2023

  • >=20 000
  • Initiatives planned to cover country, marketing, medical, ops

#Of units of Apheresis platelets collected

Target

  • 18 510

IR 2021

  • 18 148 

  • (target  was 16 280)

Progress for FY22

  • 19 627

target for 2022/2023

  • >=20 000
  • Initiatives planned to cover country, marketing, medical, ops

% First time donors aged 16 – 30 years

Target

  • >50%

IR 2021

  • 58%

  • 2021: Target was >70%

Progress for FY22

  • 69%

target for 2022/2023

  •  >=50%
  • Specific initiatives to attract age group – eg airtime
  • Targeted donor gifting campaigns (FY22-23). Youth and general donor distinction

% First time donors aged 16 – 30 years

Target

  • >50%

IR 2021

  • 58%

  • 2021: Target was >70%

Progress for FY22

  • 69%

target for 2022/2023

  •  >=50%
  • Specific initiatives to attract age group – eg airtime
  • Targeted donor gifting campaigns (FY22-23). Youth and general donor distinction

Black donors as a percent of total donors

Target

  • 37%

IR 2021

  • 45%
  • Pre Covid-19 target 46%

Progress for FY22

  • 39%
  • Target reduced to 37% (Covid-19 impacts)

target for 2022/2023

  • >=37%
  • Campaigns to increase awareness
  • Increased and alternate collection facilities post Covid-19

Black donors as a percent of total donors

Target

  • 37%

IR 2021

  • 45%
  • Pre Covid-19 target 46%

Progress for FY22

  • 39%
  • Target reduced to 37% (Covid-19 impacts)

target for 2022/2023

  • >=37%
  • Campaigns to increase awareness
  • Increased and alternate collection facilities post Covid-19

Social media engagement

Target

  • 20%

IR 2021

  • 51%

Progress for FY22

  • 26%

target for 2022/2023

  • 95% of target
  • To aid the achievement of our plans to increase social engagement appointed a social media specialist and a senior marketing and communications manager

Social media engagement

Target

  • 20%

IR 2021

  • 51%

Progress for FY22

  • 26%

target for 2022/2023

  • 95% of target
  • To aid the achievement of our plans to increase social engagement appointed a social media specialist and a senior marketing and communications manager

Whole blood collection (Group O)

Target

  • 473 452

IR 2021

  • 422 900
  • (target was 370 517)

Progress for FY22

  • 457 523
  • Covid-19 restrictions impact on collections

target for 2022/2023

  • >=498 352
  • Minimise cutbacks
  • Campaigns in place and planned
  • Increase in staff #moreblood

Whole blood collection (Group O)

Target

  • 473 452

IR 2021

  • 422 900
  • (target was 370 517)

Progress for FY22

  • 457 523
  • Covid-19 restrictions impact on collections

target for 2022/2023

  • >=498 352
  • Minimise cutbacks
  • Campaigns in place and planned
  • Increase in staff #moreblood

NAVIGATE TO:

NAVIGATE TO:

How can we help you?

Let's Connect

Head Office

  • 1 Constantia Boulevard Constantia Kloof, Roodepoort, 1709
  • (011) 761-9000
  • customerservice@sanbs.org.za

Main Links

Ⓒ 2022 - All Rights Are Reserved. SANBS Integrated Report. Created by Joshero (Pty) Ltd.

Head Office

  • 1 Constantia Boulevard Constantia Kloof, Roodepoort, 1709
  • (011) 761-9000
  • customerservice@sanbs.org.za

Main Links

Ⓒ 2022 - All Rights Are Reserved. SANBS Integrated Report. Created by Joshero (Pty) Ltd.